Browse 100000+ Jobs from 1000+ Companies by clicking on first character
e.g. jobs from "Microsoft" click on 'M', redirects you to a page which contains all companies which starts with character 'M', for "IBM" click on 'I' & so on...
C.H.
Boehringer Sohn AG & KO. KG is the parent company of Boehringer Ingelheim,
which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical
companies. Still headquartered in Ingelheim, it operates globally with 145
affiliates and more than 42,000 employees. The company's key assets of interest
are: respiratory disease, cardiovascular disease, Parkinson's disease, HIV,
thromboembolic disease and cerebrovascular disease. Since it was founded in
1885, the family-owned company has been committed to researching, developing,
manufacturing and marketing novel products of high therapeutic value for human
and veterinary medicine. Boehringer Ingelheim is a full member of the European
Federation of Pharmaceutical Industries and Associations EFPIA. The corporate
logo of Boehringer Ingelheim depicts a stylized rendition of the central
section of the imperial palace of Charlemagne.
History
History 1885: Albert Boehringer buys a
small tartar factory in Ingelheim am Rhein. The doors open and work begins on
August 1. 1886: The factory commences production of tartaric acid for use in
the food industry (e.g. in baking powder and carbonated beverages). 1893:
Albert Boehringer renames the company C. H. Boehringer Sohn (CHBS) in honour of
his father, Christoph Heinrich Boehringer. 1893: While experimenting with the
production of citric acid, lactic acid is formed. Albert Boehringer develops
this process, with the intention of producing lactic acid on a larger scale.
1895: Lactic acid is produced on an industrial scale. This becomes a commercial
success and instates CHBS as a pioneer in the field of industrial applications
of biotechnological processes. 1917: Professor Heinrich Wieland, chemist,
future Nobel Prize winner and cousin of Albert Boehringer, initiates the
foundation of the company’s research department. 1928: Albert Boehringer
purchases Dr. Karl Thomae, a company based in Winnenden near Stuttgart. 1946:
Dr. Karl Thomae GmbH is re-opened in Biberach an der Riss with a staff of 70
people. 1954: The Company hires Fritz Fischer after he is released from jail.
1955: The Animal Health division is established as the company acquires
Pfizer’s veterinary programme. 1971: The foreign subsidiary, Boehringer
Ingelheim Pharmaceuticals, Inc is founded in Ridgefield, Connecticut (USA).
This site is soon expanded, taking its place as the company’s North American
research centre. 1985: This year sees the Institute for Molecular Pathology
(IMP) established in Vienna; it opens in 1988. 1986: The biotechnological centre
in Biberach begins production of biopharmaceutical from cell cultures. 1998:
The merging of Boehringer Ingelheim KG and Dr. Karl Thomae GmbH founds
Boehringer Ingelheim Pharma KG. 2010: The company celebrates its 125th
anniversary.
CT - Ridgefield
| |
MI - Detroit
| |
CT - Ridgefield
| |
CT - Ridgefield
| |
IL - CHICAGO
| |
FL - ORLANDO
| |
AL - Montgomery
| |
United States
| |
FL - Tallahassee
| |
MN - Minneapolis
| |
FL - Bradenton
| |
CT - Ridgefield
| |
OK - Oklahoma City
| |
OK - Oklahoma City
| |
TX - Houston
| |
OH - Bedford
| |
CA - Fremont
| |
CT - Ridgefield
| |
NJ - Jersey City
| |
PA - Williamsport
| |
OH - Bedford
| |
CT - Ridgefield
| |
TX - Spring
| |
VA - Fairfax
| |
TX - ARLINGTON
| |
OH - Columbus
| |
CT - Ridgefield
| |
CT - Ridgefield
| |
PA - Pittsburgh
| |
CT - Ridgefield
| |
TN - Nashville
| |
OH - Bedford
| |
CT - Ridgefield
| |
MO - St. Joseph
| |
CT - Ridgefield
| |
IL - CHICAGO
| |
AR - Fort Smith
| |
CT - Ridgefield
| |
IA - Fort Dodge (5th Street)
| |
NY - Long Island
| |
IA - Fort Dodge (5th Street)
| |
OH - Bedford
| |
OH - Bedford
| |
OH - Columbus
| |
OH - Columbus
| |
OH - Columbus
| |
OH - Columbus
| |
CA - Fremont
| |
MI - Detroit
| |
IL - CHICAGO
|
